AbbVie (ABBV) Treasury Shares (2013 - 2026)

AbbVie (ABBV) has reported Treasury Shares for 14 consecutive years, with $10.6 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Treasury Shares rose 991.26% year-over-year to $10.6 billion in Q2 2026; TTM through Jun 2026 was $10.6 billion, a 991.26% increase from a year earlier, with the FY2025 full-year figure at $9.1 billion, up 11.52% from the prior year.
• Treasury Shares was $10.6 billion for Q2 2026 at AbbVie, roughly flat from $10.6 billion in the prior quarter.
• Over five years, Treasury Shares peaked at $77.1 million in Q2 2026 and troughed at $44.6 million in Q1 2022.
• A 5-year average of $61.3 million and a median of $64.3 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 32.28% in 2024 and jumped 1001.87% in 2026, its largest moves.
• Over 5 years, Treasury Shares stood at $4.6 billion in 2022, then jumped by 42.21% to $6.5 billion in 2023, then gained by 25.53% to $8.2 billion in 2024, then increased by 11.52% to $9.1 billion in 2025, then grew by 16.09% to $10.6 billion in 2026.
• The last three Treasury Shares figures came in at $10.6 billion (Q2 2026), $10.6 billion (Q1 2026), and $9.1 billion (Q4 2025), per Business Quant data.